Treatment response depends on deficiency severity, route of administration, underlying cause, patient age, concurrent medical conditions, and medication interactions
The resulting alterations in ITIH4 isoforms or cleavage patterns have been observed in various pathologies, making it an intriguing candidate biomarker for inflammatory diseases such as hereditary angioedema (HAE)
For many patients, pausing medication is a short-term step that greatly improves safety and reduces the likelihood of complications
Upon securing approval, you gain 24/7 access to ongoing care coordination and support
Companies developing high-quality biosimilar GLP-1 therapies with competitive pricing and proven bioequivalence will democratize access while capturing significant market share in cost-sensitive segments
However, this mechanism remains hypothetical and requires further clinical validation